Latest News - Biotech - China

From January to November of 2008, the sales revenue of Chinese manufacturing industry on biological products and biochemical products totaled RMB 64.248 billion, increasing by 29.81% YOY.

It is estimated that purchasing and stockpiling price of A (H1N1) influenza vaccines will be quite low. But the net profit rate will not be lower than common influenza vaccines, which is estimated to be about 60%.

Generally, high-price vaccines have a price reduction and low-price vaccines have a rising price. High-price products like Measles Mumps& Rubella Vaccine Live and Measles & Rubella Combined Vaccine (MR) have a price reduction of 35% and 47%.

SHENZHEN, China, Sept. 9 /PRNewswire-Asia/ -- Shenzhen Beike Biotechnology Co. Ltd. A leader in stem cell research and regenerative medicine, announced the appointment of two senior stem cell scientists to key positions in the company.

In 2009, 23.3 million populations will need vaccinating, accounting for 31% of the populations that should be vaccinated.

This report examines the current state of the disease management industry, highlights the challenges and opportunities facing the industry, and discusses technology's role in driving innovations in new care management models.

WWW.SHCRI.COM -- Research Report on Global and Chinese Blood Product Industry, 2009

WWW.SHCRI.COM -- Research Report on China's foot-and-mouth disease Vaccine (FMD Vaccine) Industry, 2009

NEVER SAY DIE! Death is for poor people, RICH can live a great life again, and again... IF...

New health care discovery non-toxic natural chemotherapy TM, to get rid of cancer...

"MIND ACUPUNCTURE TM" NEW HEALTH CARE DISCOVERY, to cure mind body diseases...time is of essence to start as soon as possible to do it...

Fantastic Idea: Use of TCM & Acupuncture Medicine to help to learn a new language...idea has arrived and it is going to help millions of Chinese English Language Learners...

Research Report on China's Biopharmaceutical Industry, 2009

EnoGene’s Italian distributor, the ISO 9001 certified company Prodotti Gianni SpA, since 1950 in the research market, is promoting EnoGene’s high quality antibody products and services in Italy.

Breakthrough technology in microscopy brings advancements that provide customers with the power to discover things they have never seen before, and to solve problems never before solvable.

Infinity I-China announced on that it has joined with Kleiner Perkins Caufield & Byers China, the China Spring Fund and JAIC in a Series B Financing round of Chiral Quest Corporation.

ResearchInChina announces the release of a new report - China Blood Products Industry Report, 2007-2008. For ordering information please contact us at report@researchinchina.com or at 86-10-82600821.

Market Report on China's Biopharmaceutical Industry, 2008-2010

Suzlon Energy, the largest wind turbine manufacturer in Asia and the fifth largest in the world, has just signed a training deal with China-based training firm Yaxley Education.

Research Report on China Blood Product Market, 2008

Liquid fuel synthesis: Making it up as you go along

Americans are going to China for stem cell treatments and having success.